American CryoStem Corporation
3 clinical trials · Sponsor
◉ Watch American CryoStem Corporation
| Record | Firm | Date |
|---|---|---|
| Treatment of Long COVID Symptoms Utilizing Autologous Stem Cells Following COVID-19 Infection (NCT05669261) | American CryoStem Corporation | 2023-08-01 |
| ATCellâ„¢ Expanded Autologous, Adipose-Derived Mesenchymal Stem Cells Deployed Via Intravenous Infusion (NCT04744051) | American CryoStem Corporation | 2021-02-01 |
Track American CryoStem Corporation automatically
Every clearance here is in the API, with alerts when new ones post.